Stock A293780 APTABIO THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart AptaBio Therapeutics Inc.

Equities

A293780

KR7293780003

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 02/06/2024 BST 		5-day change 1st Jan Change
5,750 KRW -1.88% Intraday chart for AptaBio Therapeutics Inc. +10.15% -36.46%
2023 AptaBio Therapeutics Inc. announced that it has received KRW 49.999966652 billion in funding CI
2023 AptaBio Therapeutics Inc. announced that it expects to receive KRW 49.999966652 billion in funding CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
APTABIO THERAPEUTICS INC. Stock AptaBio Therapeutics Inc.
 93.48M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 107B
BIONTECH SE Stock BioNTech SE
 24.82B -
ARGENX SE Stock argenx SE
 22.48B -
GENMAB A/S Stock Genmab A/S
 18.32B
  1. Stock Market
  2. Equities
  3. A293780 Stock
  4. Charts AptaBio Therapeutics Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW